North America Breast Cancer Diagnostics Market Size & Outlook
North America breast cancer diagnostics market, 2018-2030 (US$M)
Related Markets
North America breast cancer diagnostics market highlights
- The North America breast cancer diagnostics market generated a revenue of USD 7,926.5 million in 2023.
- The market is expected to grow at a CAGR of 7.9% from 2024 to 2030.
- In terms of segment, outpatient facilities was the largest revenue generating end use in 2023.
- Home Care is the most lucrative end use segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 7,926.5 million |
| Market revenue in 2030 | USD 13,523.0 million |
| Growth rate | 7.9% (CAGR from 2023 to 2030) |
| Largest segment | Outpatient facilities |
| Fastest growing segment | Home Care |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
| Key market players worldwide | BD, Danaher Corp, Koninklijke Philips NV, Qiagen NV, Thermo Fisher Scientific Inc, Myriad Genetics Inc, Argon Medical Devices, Roche Holding AG ADR, Hologic Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 45.8% of the global breast cancer diagnostics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 6,801.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Breast Cancer Diagnostics Market Scope
Breast Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America breast cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 61.57% in 2023. Horizon Databook has segmented the North America breast cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the market in 2020. Increase in awareness about breast cancer and presence of highly established healthcare infrastructure are among the key factors contributing to market growth. Blood testing and genomic tests are growing markets in North America and are anticipated to show a lucrative growth rate over the forecast period. Currently, breast cancer diagnostics are the fastest growing market in the region.
Advanced diagnostic tests available in the region can provide better sensitivity, specificity, and accuracy, leading to a rapid increase in their demand. Increasing requirement of genomic tests for personalized healthcare in disease areas such as cancer is expected to further drive market growth. Moreover, local presence of key players such as Hologic, BD, and Qiagen in this region is anticipated to positively impact the overall market growth.
North America held major market share, particularly the U.S., owing to increasing awareness about the benefits of early detection of breast cancer. This has driven the U.S.-based firms to make considerable investments in developing companion diagnostics for use with targeted therapeutics.
Reasons to subscribe to North America breast cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America breast cancer diagnostics market databook
-
Our clientele includes a mix of breast cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America breast cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into North America breast cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America breast cancer diagnostics market size, by country, 2018-2030 (US$M)
North America Breast Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
